28 Results for "

LpxC

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "LpxC" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-15460
CAS No.: 728865-23-4
Purity:  98.58%
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

CHIR-090 is a potent, slow, tight-binding inhibitor of the LpxC deacetylase. It binds to E. coli LpxC with a Ki of 4.0 nM. CHIR-090 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-131981
CAS No.: 2427584-96-9
Purity:  99.86%
Target:  

Bacterial

Research Areas:  

Infection Cardiovascular Disease

TP0586532 is a non-hydroxamate LpxC inhibitor (IC50=0.101 μM). TP0586532 as a compound with a low cardiovascular risk that is effective against K. pneumoniae, including resistant strains . TP0586532 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19936A
CAS No.: 1410809-37-8
Target:  

Bacterial

Research Areas:  

Infection

ACHN-975 TFA is a selective LpxC inhibitor and exhibits a subnanomolar LpxC inhibitory activity. ACHN-975 TFA is against a wide range of gram-negative bacterias with low MIC values (≤1 μg/mL) .
loading...
    loading...
Cat. No.: HY-103251
CAS No.: 1312473-63-4
Purity:  99.42%
Synonyms: LpxC-4
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

PF-5081090 (LpxC-4) is a potent LpxC inhibitor, is a rapidly bactericidal with broad-spectrum activity. PF-5081090 serves as a regulator of lipid A biosynthesis in Gram-negative pathogens .
loading...
    loading...
Cat. No.: HY-W585865
CAS No.: 112710-84-6
Synonyms: UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine Tris
UDP-3-O-acyl-GlcNAc Tris (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine Tris) serves as a deacetylation substrate and biosynthetic intermediate in the biosynthetic pathways of lipid A and Kdo2-lipid A in Escherichia coli. UDP-3-O-acyl-GlcNAc Tris undergoes enzymatic deacetylation via LpxC to produce UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine and release acetate. UDP-3-O-acyl-GlcNAc Tris accumulates in Escherichia coli extracts in the absence of [(R)-3-hydroxymyristoyl]-acyl carrier protein. UDP-3-O-acyl-GlcNAc Tris can be used in studies related to Gram-negative shock .
loading...
    loading...
Cat. No.: HY-19936
CAS No.: 1410809-36-7
Target:  

Bacterial

Research Areas:  

Infection

ACHN-975 is a selective LpxC inhibitor and exhibits a subnanomolar LpxC inhibitory activity. ACHN-975 is against a wide range of gram-negative bacterias with low MIC values (≤1 μg/mL) .
loading...
    loading...
Cat. No.: HY-147237
CAS No.: 2413574-64-6
Purity:  96.04%
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-10 (Compound A) is a high selectivity inhibitor of LpxC. LpxC-IN-10 exhibits MIC values of 0.5 μg/mL against E. coli and K. pneumoniae. LpxC-IN-10 (Compound A) can be used for the research of bacterial infection . LpxC-IN-10 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-153518
CAS No.: 1219365-61-3
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-11 (Compound 1) is an LpxC inhibitor. LpxC-IN-11 can be used in the research of bacterial infectious diseases .
loading...
    loading...
Cat. No.: HY-B0967
CAS No.: 131-69-1
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Phthalylsulfacetamide is an orally active sulfonamide antibiotic and New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 15.4 μM. Phthalylsulfacetamide stably binds to the active hydrolysis center of NDM-1, interacts with Zn2+, and interacts with key amino acid residues Val73 and His122 to inhibit enzyme activity. Phthalylsulfacetamide can be used for the research of Escherichia coli infection .
loading...
    loading...
Cat. No.: HY-W087058
CAS No.: 1012-72-2
Target:  

Topoisomerase

Research Areas:  

Infection

1,4-Di-tert-butylbenzene is a volatile compound identified in the hexane extracts of corn cob and green millet. 1,4-Di-tert-butylbenzene shows potent inhibition against receptor proteins of Bacterial type II topoisomerase (4PLB and LpxC) in docking analysis .
loading...
    loading...
Cat. No.: HY-172734
CAS No.: 2919723-66-1
Target:  

Bacterial

Research Areas:  

Infection

FG-2101 is a selective and orally active non-hydroxamate LpxC inhibitor with an IC50 of ~1 nM. FG-2101 exhibits exquisite selectivity over other bacterial and human metalloenzymes. FG-2101 can be used for the study of Gram-negative bacteria infections including drug-resistant strains .
loading...
    loading...
Cat. No.: HY-131907
CAS No.: 2253951-38-9
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-5 is a potent non-hydroxamate LpxC (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor with an IC50 of 20 nM. LpxC-IN-5 shows antibacterial activity against E. coli ATCC25922, P. aeruginosa ATCC27853, K. pneumoniae ATCC13883 and P. aeruginosa 5567 with MIC of 16, 4, 64, and 4 μg/mL, respectively .
loading...
    loading...
Cat. No.: HY-121021
CAS No.: 207732-11-4
Target:  

Bacterial

Research Areas:  

Infection

BB-78485 is an LpxC metalloenzyme inhibitor with antibacterial activity. BB-78485 can inhibit LpxC with an IC50 value of 160 nM. BB-78485 can be used for the research of gram-negative selective antibacterials .
loading...
    loading...
Cat. No.: HY-146650
CAS No.: 2756125-46-7
Target:  

Bacterial

Research Areas:  

Infection Cardiovascular Disease

LpxC-IN-9 (compound 19) is a potent LpxC inhibitor. LpxC-IN-9 has antibacterial and hypotensive effects . LpxC-IN-9 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-125789
CAS No.: 1289620-49-0
Purity:  99.58%
Target:  

Bacterial

Research Areas:  

Infection

PF-04753299 is a potent and selective UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitor. PF-04753299 is bactericidal for the gonococcal isolates. PF-04753299 inhibits E. coli, P. aeruginosa and K. pneumoniae strains with MIC90 values of 2 μg/ml, 4 μg/ml and 16 μg/ml, respectively. PF-04753299 is used for the study of gram-negative bacteria infection .
loading...
    loading...
Cat. No.: HY-179396
CAS No.: 1884551-35-2
Target:  

Bacterial

Research Areas:  

Infection

T-1228 is a highly selective LpxC inhibitor. T-1228 can effectively block the synthesis of LPS (HY-D1056), causing defects in the bacterial outer membrane structure, increasing membrane permeability, and ultimately leading to bacterial cell death. T-1228 can be used for the study of Gram-negative bacterial infections .
loading...
    loading...
Cat. No.: HY-103251R
CAS No.: 1312473-63-4
Synonyms: LpxC-4 (Standard)
Research Areas:  

Infection

Cefalonium (dihydrate) (Standard) is the analytical standard of Cefalonium (dihydrate). This product is intended for research and analytical applications. Cefalonium dihydrate is a cephalosporin antibiotic. Cefalonium (dihydrate) is effective against Staphylococcus aureus. Cefalonium (dihydrate) has anti-inflammatory and antibacterial activities .
loading...
    loading...
Cat. No.: HY-168100
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-14 (compound 6i) is a potent LpxC inhibitor. LpxC-IN-14 shows antibacterial activity. LpxC-IN-14 shows low cytotoxicity. LpxC-IN-14 shows acceptable plasma protein binding .
loading...
    loading...
Cat. No.: HY-172945
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-16 (Compound P-2) is an LpxC inhibitor. LpxC-IN-16 has anti-MDR P. aeruginosa activity .
loading...
    loading...
Cat. No.: HY-158682
CAS No.: 3033881-14-7
Target:  

Bacterial

Research Areas:  

Infection

LpxC-IN-13 (Compound 13) is a LpxC inhibitor, with an IC50 18.06 nM. LpxC-IN-13 effectively inhibits Gram-negative bacterial infection .
loading...
    loading...